Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYRoche’s IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone met one of its co-primary endpointsPREV STORYCB2 Insights Announces Record Annual Revenue of $13.4 million for FY 2019 Sequential Growth of 25%